The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells

Nutritional factors can affect the risk of developing neurological disorders and their rate of progression. In particular, abnormalities of carbohydrate metabolism in diabetes mellitus patients lead to an increased risk of neurological disorders such as Alzheimer’s disease (AD). In this study, we in...

Full description

Bibliographic Details
Main Authors: Ryuto Nasu, Ayako Furukawa, Keita Suzuki, Masayoshi Takeuchi, Yoshiki Koriyama
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/10/2958
_version_ 1797552399840182272
author Ryuto Nasu
Ayako Furukawa
Keita Suzuki
Masayoshi Takeuchi
Yoshiki Koriyama
author_facet Ryuto Nasu
Ayako Furukawa
Keita Suzuki
Masayoshi Takeuchi
Yoshiki Koriyama
author_sort Ryuto Nasu
collection DOAJ
description Nutritional factors can affect the risk of developing neurological disorders and their rate of progression. In particular, abnormalities of carbohydrate metabolism in diabetes mellitus patients lead to an increased risk of neurological disorders such as Alzheimer’s disease (AD). In this study, we investigated the relationship between nervous system disorder and the pathogenesis of AD by exposing SH-SY5Y neuroblastoma cells to glyceraldehyde (GA). We previously reported that GA-derived toxic advanced glycation end products (toxic AGEs, TAGE) induce AD-like alterations including intracellular tau phosphorylation. However, the role of TAGE and their target molecules in the pathogenesis of AD remains unclear. In this study, we investigated the target protein for TAGE by performing two-dimensional immunoblot analysis with anti-TAGE antibody and mass spectrometry and identified β-tubulin as one of the targets. GA treatment induced TAGE-β-tubulin formation and abnormal aggregation of β-tubulin, and inhibited neurite outgrowth in SH-SY5Y cells. On the other hand, glucose-derived AGEs were also involved in developing AD. However, glucose did not make abnormal aggregation of β-tubulin and did not inhibit neurite outgrowth. Understanding the underlying mechanism of TAGE-β-tubulin formation by GA and its role in neurodegeneration may aid in the development of novel therapeutics and neuroprotection strategies.
first_indexed 2024-03-10T16:00:28Z
format Article
id doaj.art-1cc1acd8d47f4ad3b271334a3393e481
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T16:00:28Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-1cc1acd8d47f4ad3b271334a3393e4812023-11-20T15:17:52ZengMDPI AGNutrients2072-66432020-09-011210295810.3390/nu12102958The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma CellsRyuto Nasu0Ayako Furukawa1Keita Suzuki2Masayoshi Takeuchi3Yoshiki Koriyama4Graduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki, Suzuka 513-8670, JapanGraduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki, Suzuka 513-8670, JapanGraduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki, Suzuka 513-8670, JapanDepartment of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada-machi, Ishikawa 920-0293, JapanGraduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki, Suzuka 513-8670, JapanNutritional factors can affect the risk of developing neurological disorders and their rate of progression. In particular, abnormalities of carbohydrate metabolism in diabetes mellitus patients lead to an increased risk of neurological disorders such as Alzheimer’s disease (AD). In this study, we investigated the relationship between nervous system disorder and the pathogenesis of AD by exposing SH-SY5Y neuroblastoma cells to glyceraldehyde (GA). We previously reported that GA-derived toxic advanced glycation end products (toxic AGEs, TAGE) induce AD-like alterations including intracellular tau phosphorylation. However, the role of TAGE and their target molecules in the pathogenesis of AD remains unclear. In this study, we investigated the target protein for TAGE by performing two-dimensional immunoblot analysis with anti-TAGE antibody and mass spectrometry and identified β-tubulin as one of the targets. GA treatment induced TAGE-β-tubulin formation and abnormal aggregation of β-tubulin, and inhibited neurite outgrowth in SH-SY5Y cells. On the other hand, glucose-derived AGEs were also involved in developing AD. However, glucose did not make abnormal aggregation of β-tubulin and did not inhibit neurite outgrowth. Understanding the underlying mechanism of TAGE-β-tubulin formation by GA and its role in neurodegeneration may aid in the development of novel therapeutics and neuroprotection strategies.https://www.mdpi.com/2072-6643/12/10/2958toxic advanced glycation-end products (TAGE)glyceraldehyde (GA)Alzheimer’s disease (AD)diabetes mellitus (DM)β-tubulinneurite outgrowth
spellingShingle Ryuto Nasu
Ayako Furukawa
Keita Suzuki
Masayoshi Takeuchi
Yoshiki Koriyama
The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
Nutrients
toxic advanced glycation-end products (TAGE)
glyceraldehyde (GA)
Alzheimer’s disease (AD)
diabetes mellitus (DM)
β-tubulin
neurite outgrowth
title The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
title_full The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
title_fullStr The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
title_full_unstemmed The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
title_short The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
title_sort effect of glyceraldehyde derived advanced glycation end products on β tubulin inhibited neurite outgrowth in sh sy5y human neuroblastoma cells
topic toxic advanced glycation-end products (TAGE)
glyceraldehyde (GA)
Alzheimer’s disease (AD)
diabetes mellitus (DM)
β-tubulin
neurite outgrowth
url https://www.mdpi.com/2072-6643/12/10/2958
work_keys_str_mv AT ryutonasu theeffectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT ayakofurukawa theeffectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT keitasuzuki theeffectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT masayoshitakeuchi theeffectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT yoshikikoriyama theeffectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT ryutonasu effectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT ayakofurukawa effectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT keitasuzuki effectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT masayoshitakeuchi effectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells
AT yoshikikoriyama effectofglyceraldehydederivedadvancedglycationendproductsonbtubulininhibitedneuriteoutgrowthinshsy5yhumanneuroblastomacells